The acquisition of the home health and hospice provider Amedisys by the insurance mammoth UnitedHealth Group (NYSE: UNH) has far-reaching implications for the hospice community. The UnitedHealth Group subsidiary Optum in June 2023 inked its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. After leaping a series […]
Consolidation among nonprofit hospices has ramped up in recent years. The trend is not anticipated to abate any time soon amid rising costs and regulatory oversight. This is according to Mark Kulik, senior managing director at the Pennsylvania-based merger and acquisition advisory firm The Braff Group. Hospice consolidation activity has increased over the past few […]
Tariffs being implemented by the Trump administration could have a dampening effect on an already slumping hospice mergers and acquisitions market. Economic uncertainty has swirling around these trade policies. Tariffs tend to raise prices and often trigger interest rate increases by the Federal Reserve. This makes financing debt more expensive, and many buyers in the […]
In this episode of Hospice News Elevate, senior editor Jim Parker speaks with Mark Kulik, senior managing director for The Braff Group, about consolidation occurring in the nonprofit hospice space. A rising number of nonprofits are affiliating with one another or selling to for-profit companies. This episode discusses the leading trends. Tune in now!
Trends in hospice merger and acquisition (M&A) activity thus far in 2025 are diverting from industry expectations in varied ways as multi-pronged headwinds impact decision-making processes. The types of hospice transactions that have unfolded halfway through the year hold revealing signs of where the industry is headed on the horizon, according to Joe Widmar, director […]
Predictions of a hospice M&A rebound have fizzled as a volatile regulatory and economic climate threatens to curb transaction activity in 2025 and beyond. Among the recent changes impacting strategic hospice decisions is the unfurling of the Trump administration’s new reciprocal tariff policy, according to Mark Kulik, senior managing director at The Braff Group. The […]
Hospices that have palliative care service lines may be better poised for growth in the merger and acquisition landscape compared to others. But the ability to demonstrate sustainability and scalability of these services will be crucial to manifesting a return on investment. Investors’ interest in palliative care has slowly mounted in recent years, with these […]
Hospice leaders will need to keep their eyes on five key trends in the new year when it comes to compliance, business operations and finance. Coupled with these trends is rising utilization. Hospice utilization reached 51.7% among Medicare decedents in 2023, up more than two percentage points from the prior year, according to recent data […]
Quality, compliance and financial stability are top of mind in hospice merger and acquisitions (M&A) as this year comes to an end. Stakeholders are projecting a more frothy market in 2025, though regulatory concerns could sway buying decisions. Growing demand is among the constants driving investor interest in the hospice space, according to Tom Lillis, […]
The Federal Reserve cut interest rates by 0.5% on Wednesday, which will likely have an impact on hospice M&A. Interest rates have widespread implications for the hospice mergers and acquisitions market, particularly when it comes to private equity investments. PE firms, and some publicly traded companies, tend to finance their acquisitions by taking on debt. […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
